BrainChild Bio: Funding, Investors & Team (Sep 2026)
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors. They use CAR-T cell technology to create treatments for tumors in the central nervous system, particularly focusing on DIPG. Their research is based on previous studies at Seattle Children's Hospital and their goal is to offer new treatments for incurable brain cancers in children.
BrainChild Bio has raised $116M across 2 funding rounds on record, the most recent a Series A of $116M announced in Sep 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BrainChild Bio Company Profile and Key Stats
Latest funding round on record: Sep 2026.
BrainChild Bio Funding Rounds
BrainChild Bio raised $300k in an undisclosed round announced in Jan 2025.
1.7 years later, a Series A of $116M was announced in Sep 2026.
BrainChild Bio Investors
BrainChild Bio Founders and Leadership Team
Contact details for the BrainChild Bio team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →BrainChild Bio Funding Compared to Other Biotechnology Startups
BrainChild Bio's latest round of $116M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BrainChild Bio in Biotechnology and Seattle
Companies Similar to BrainChild Bio
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
BrainChild Bio Funding FAQs
What does BrainChild Bio do?
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors. They use CAR-T cell technology to create treatments for tumors in the central nervous system, particularly focusing on DIPG. Their research is based on previous studies at Seattle Children's Hospital and their goal is to offer new treatments for incurable brain cancers in children.
How much funding has BrainChild Bio raised?
BrainChild Bio has raised $116M across 2 rounds on record. The most recent is a Series A of $116M announced in Sep 2026.
When did BrainChild Bio last raise funding?
BrainChild Bio's most recent funding round on record is a Series A of $116M, announced in Sep 2026.
Who has invested in BrainChild Bio?
Investors on record for BrainChild Bio include WRF Capital, Seattle Children’s, ScaleReady.
Who founded BrainChild Bio?
FundedIQ lists Michael Jensen (Founder) at BrainChild Bio.
Where is BrainChild Bio headquartered?
BrainChild Bio is based in Seattle, Washington, United States.
How many employees does BrainChild Bio have?
BrainChild Bio is in the 11-50 employee band.
When was BrainChild Bio founded?
BrainChild Bio was founded in 2023.
How does BrainChild Bio's funding compare to other Biotechnology startups?
BrainChild Bio's latest round of $116M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's BrainChild Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BrainChild Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.